Mrs Barbara H Shumard, LMSW | |
3661 Terrace Hills Ln, Jackson, MI 49203-4891 | |
(734) 425-0396 | |
(734) 425-0396 |
Full Name | Mrs Barbara H Shumard |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 3661 Terrace Hills Ln, Jackson, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275756249 | NPI | - | NPPES |
0963228 | Other | BCN | |
0963228 | Other | BCBS | |
126240 | Other | VALUE OPTIONS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 4101005924 (Michigan) | Secondary |
1041C0700X | Social Worker - Clinical | 6801014716 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Barbara H Shumard, LMSW 3661 Terrace Hills Ln, Jackson, MI 49203-4891 Ph: (734) 425-0396 | Mrs Barbara H Shumard, LMSW 3661 Terrace Hills Ln, Jackson, MI 49203-4891 Ph: (734) 425-0396 |
News Archive
Elderly cancer patients need a combination of treatments tailor-made to their specific needs to successfully combat the disease. The challenge is to boost their immune response to cancer vaccines, because like the rest of our organs, our immune system ages and gradually becomes less efficient as we get older.
Results from a Mayo Clinic laboratory study in animals suggest that using distraction osteogenesis, a procedure that uses the mechanical force of an appliance to lengthen soft tissue and bone, may be a feasible and effective method to repair cleft palate in the future.
VIVUS, Inc. today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa, an investigational new drug candidate for the treatment of obesity. The three new patents are the second, third, and fourth patents to be granted in a series of patent applications VIVUS has filed that are directed to the Qnexa product and methods of using Qnexa in various therapeutic applications.
UCLA researchers have received 80 American Recovery and Reinvestment Act of 2009 (Recovery Act) grants totaling $19.4 million from the National Institutes of Health thus far. UCLA's largest NIH ARRA grant to date was $1.9 million, awarded to UCLA's Laboratory of Neuro Imaging (LONI), which is dedicated to creating scientific approaches to mapping how the brain is structured and how it works.
› Verified 3 days ago